TTR vs. AL cardiac amyloidosis: Don't rely on imaging alone July 08, 2019 Overview إظهار النسخة النصية Overview Mayo Clinic cardiologists Martha Grogan, M.D., and Omar F. Abou Ezzeddine, M.D., C.M., M.S., discuss transthyretin (TTR) amyloidosis and amyloid light chain (AL) amyloidosis. General characteristics of cardiac amyloidosis can include unexplained heart failure, unexplained atrial fibrillation, and physical exam findings such as jugular venous pressure elevation, lower extremity edema, and abdominal distension. Diagnosis and treatment of amyloidosis vary depending on the type. Patients with amyloidosis can deteriorate rapidly, so diagnosing quickly is very important. This video first appeared on theheart.org | Medscape Cardiology. | VID-20464757 المتخصصون في المجالات الطبية TTR vs. AL cardiac amyloidosis: Don't rely on imaging alone